Determining the Pharmacokinetics and Long-Term Biodistribution of SiO2 Nanoparticles In Vivo Using Accelerator Mass Spectrometry
Source abstract
Abstract
Biodistribution is an important factor in better understanding silica dioxide nanoparticle (SiNP) safety. Currently, comprehensive studies on biodistribution are lacking, most likely due to the lack of suitable analytical methods. Accelerator mass spectrometry was used to investigate the relationship between administered dose, pharmacokinetics (PK), and long-term biodistribution of (14)C-SiNPs in vivo. PK analysis showed that SiNPs were rapidly cleared from the central compartment, were distributed to tissues of the reticuloendothelial system, and persisted in the tissue over the 8 week time course, raising questions about the potential for bioaccumulation and associated long-term effects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California
Battelle Center for Fundamental and Applied Systems Toxicology (B-FAST), Battelle, Columbus, Ohio
References (43)
Show source-provided references
1. Yang J. · Langmuir · 2008 · 24 · 341710.1021/la701688t ↗
2. Iezzi E. B. · J. Am. Chem. Soc. · 2002 · 124 · 52410.1021/ja0171005 ↗
3. Zhao X. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 1502710.1073/pnas.0404806101 ↗
4. Hirsch L. R. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
5. Huo Q. S. · J. Am. Chem. Soc. · 2006 · 128 · 644710.1021/ja060367p ↗
6. Roy I. · Proc. Natl. Acad. Sci. U.S.A. · 2005 · 102 · 27910.1073/pnas.0408039101 ↗
7. Slowing I. I. · J. Am. Chem. Soc. · 2007 · 129 · 884510.1021/ja0719780 ↗
8. Lin W. · Toxicol. Appl. Pharmacol. · 2006 · 217 · 25210.1016/j.taap.2006.10.004 ↗
9. Xie G. · Arch. Toxicol. · 2010 · 84 · 18310.1007/s00204-009-0488-x ↗
10. Fischer H. C. · Curr. Opin. Biotechnol. · 2007 · 18 · 56510.1016/j.copbio.2007.11.008 ↗
11. Colvin V. L. · Nat. Biotechnol. · 2003 · 21 · 116610.1038/nbt875 ↗
12. Saffiotti U. · Prog. Clin. Biol. Res. · 1992 · 374 · 51
13. Merget R. · Arch. Toxicol. · 2002 · 75 · 62510.1007/s002040100266 ↗
14. Kirchner C. · Nano Lett. · 2005 · 5 · 33110.1021/nl047996m ↗
15. Choi H. S. · Nat. Biotechnol. · 2007 · 25 · 116510.1038/nbt1340 ↗
16. Kamps J. A. · Proc. Natl. Acad. Sci. U.S.A. · 1997 · 94 · 1168110.1073/pnas.94.21.11681 ↗
17. Krieger M. · Annu. Rev. Biochem. · 1994 · 63 · 60110.1146/annurev.bi.63.070194.003125 ↗
18. Liu Z. · Nat. Nanotechnol. · 2007 · 2 · 4710.1038/nnano.2006.170 ↗
19. Singh R. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 335710.1073/pnas.0509009103 ↗
20. Cho M. · Toxicol. Lett. · 2009 · 189 · 17710.1016/j.toxlet.2009.04.017 ↗
21. He Q. · Small · 2011 · 7 · 27110.1002/smll.201001459 ↗
22. Liu T. · Biomaterials · 2011 · 32 · 165710.1016/j.biomaterials.2010.10.035 ↗
23. He X. · Anal. Chem. · 2008 · 80 · 959710.1021/ac801882g ↗
24. Yu T. · J. Controlled Release · 2012 · 163 · 4610.1016/j.jconrel.2012.05.046 ↗
25. Kumar R. · ACS Nano · 2010 · 4 · 69910.1021/nn901146y ↗
26. Vogel J. S. · Anal. Chem. · 1995 · 67 · A35310.1021/ac00107a714 ↗
27. Lappin G. · Anal. Bioanal. Chem. · 2004 · 378 · 35610.1007/s00216-003-2348-5 ↗
28. Turteltaub K. W. · Carcinogenesis · 1990 · 11 · 4310.1093/carcin/11.1.43 ↗
29. Frantz C. E. · Carcinogenesis · 1995 · 16 · 36710.1093/carcin/16.2.367 ↗
30. Dueker S. R. · J. Lipid Res. · 2000 · 41 · 179010.1016/S0022-2275(20)31972-6 ↗
31. Wang W. · J. Am. Chem. Soc. · 2001 · 123 · 1252810.1021/ja011262j ↗
32. Stöber W. · J. Colloid Interface Sci. · 1968 · 26 · 6210.1016/0021-9797(68)90272-5 ↗
33. Creek M. R. · Carcinogenesis · 1997 · 18 · 242110.1093/carcin/18.12.2421 ↗
34. Ognibene T. J. · Anal. Chem. · 2003 · 75 · 219210.1021/ac026334j ↗
35. Turteltaub K. W. · Proc. Natl. Acad. Sci. U.S.A. · 1990 · 87 · 528810.1073/pnas.87.14.5288 ↗
36. Vogel J. S. · Radiocarbon · 1992 · 34 · 33310.1017/S0033822200063529 ↗
37. van Schooneveld M. M. · Nano Lett. · 2008 · 8 · 251710.1021/nl801596a ↗
38. Saba T. M. · Arch. Intern. Med. · 1970 · 126 · 103110.1001/archinte.1970.00310120093014 ↗
39. Opanasopit P. · Crit. Rev. Ther. Drug Carrier Syst. · 2002 · 19 · 19110.1615/CritRevTherDrugCarrierSyst.v19.i3.10 ↗
40. Li S. D. · Mol Pharm · 2008 · 5 · 49610.1021/mp800049w ↗
41. Mamaeva, V.; Sahlgren, C.; Linden, M.Adv. Dru. Delivery Rev. 2012, not supplied.
42. Levi A. J. · J. Clin. Invest. · 1969 · 48 · 215610.1172/JCI106182 ↗
43. Chen Z. · Toxicol. Appl. Pharmacol. · 2008 · 230 · 36410.1016/j.taap.2008.03.022 ↗